$TRVI Income Statement | Understand Stock

$TRVI

$13.35 +$0.84 (6.71%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income, net
Other expense, net
Change in fair value of term loan derivative liability
Other expense
Interest expense
Total other income, net

Loss before income taxes
Income tax benefit
Net loss
Basic and diluted net loss per common share outstanding
Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted
Other comprehensive income:
Net unrealized gains on available-for-sale marketable securities
Comprehensive loss
Basic net loss per common share outstanding
Diluted net loss per common share outstanding
Weighted average common shares used in net loss per share attributable to common stockholders, basic
Weighted average common shares used in net loss per share attributable to common stockholders, diluted

Comments